Cargando…

The COVID-19 Preventive Behaviors Index: Development and Validation in Two Samples From the United Kingdom

Monitoring compliance with, and understanding the factors affecting, COVID-19 preventive behaviors requires a robust index of the level of subjective likelihood that the individual will engage in key COVID-19 preventive behaviors. In this article, the psychometric properties of the COVID-19 Preventi...

Descripción completa

Detalles Bibliográficos
Autores principales: Breakwell, Glynis M., Fino, Emanuele, Jaspal, Rusi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164547/
https://www.ncbi.nlm.nih.gov/pubmed/33430623
http://dx.doi.org/10.1177/0163278720983416
_version_ 1783701140219625472
author Breakwell, Glynis M.
Fino, Emanuele
Jaspal, Rusi
author_facet Breakwell, Glynis M.
Fino, Emanuele
Jaspal, Rusi
author_sort Breakwell, Glynis M.
collection PubMed
description Monitoring compliance with, and understanding the factors affecting, COVID-19 preventive behaviors requires a robust index of the level of subjective likelihood that the individual will engage in key COVID-19 preventive behaviors. In this article, the psychometric properties of the COVID-19 Preventive Behaviors Index (CPBI), including its development and validation in two samples in the United Kingdom, are described. Exploratory and confirmatory factor analyses were performed on data from 470 participants in the United Kingdom who provided demographic information and completed the Fear of COVID-19 Scale, the COVID-19 Own Risk Appraisal Scale (CORAS) and the CPBI. Results showed that a unidimensional, 10-item model fits the data well, with satisfactory fit indices, internal consistency and high item loadings onto the factor. The CPBI correlated positively with both fear and perceived risk of COVID-19, suggesting good concurrent validity. The CPBI is a measure of the likelihood of engaging in preventive activity, rather than one of intention or actual action. It is adaptable enough to be used over time as a monitoring instrument by policy makers and a modeling tool by researchers.
format Online
Article
Text
id pubmed-8164547
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-81645472021-06-09 The COVID-19 Preventive Behaviors Index: Development and Validation in Two Samples From the United Kingdom Breakwell, Glynis M. Fino, Emanuele Jaspal, Rusi Eval Health Prof COVID-19 and the Health Professions Monitoring compliance with, and understanding the factors affecting, COVID-19 preventive behaviors requires a robust index of the level of subjective likelihood that the individual will engage in key COVID-19 preventive behaviors. In this article, the psychometric properties of the COVID-19 Preventive Behaviors Index (CPBI), including its development and validation in two samples in the United Kingdom, are described. Exploratory and confirmatory factor analyses were performed on data from 470 participants in the United Kingdom who provided demographic information and completed the Fear of COVID-19 Scale, the COVID-19 Own Risk Appraisal Scale (CORAS) and the CPBI. Results showed that a unidimensional, 10-item model fits the data well, with satisfactory fit indices, internal consistency and high item loadings onto the factor. The CPBI correlated positively with both fear and perceived risk of COVID-19, suggesting good concurrent validity. The CPBI is a measure of the likelihood of engaging in preventive activity, rather than one of intention or actual action. It is adaptable enough to be used over time as a monitoring instrument by policy makers and a modeling tool by researchers. SAGE Publications 2021-01-12 2021-03 /pmc/articles/PMC8164547/ /pubmed/33430623 http://dx.doi.org/10.1177/0163278720983416 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle COVID-19 and the Health Professions
Breakwell, Glynis M.
Fino, Emanuele
Jaspal, Rusi
The COVID-19 Preventive Behaviors Index: Development and Validation in Two Samples From the United Kingdom
title The COVID-19 Preventive Behaviors Index: Development and Validation in Two Samples From the United Kingdom
title_full The COVID-19 Preventive Behaviors Index: Development and Validation in Two Samples From the United Kingdom
title_fullStr The COVID-19 Preventive Behaviors Index: Development and Validation in Two Samples From the United Kingdom
title_full_unstemmed The COVID-19 Preventive Behaviors Index: Development and Validation in Two Samples From the United Kingdom
title_short The COVID-19 Preventive Behaviors Index: Development and Validation in Two Samples From the United Kingdom
title_sort covid-19 preventive behaviors index: development and validation in two samples from the united kingdom
topic COVID-19 and the Health Professions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164547/
https://www.ncbi.nlm.nih.gov/pubmed/33430623
http://dx.doi.org/10.1177/0163278720983416
work_keys_str_mv AT breakwellglynism thecovid19preventivebehaviorsindexdevelopmentandvalidationintwosamplesfromtheunitedkingdom
AT finoemanuele thecovid19preventivebehaviorsindexdevelopmentandvalidationintwosamplesfromtheunitedkingdom
AT jaspalrusi thecovid19preventivebehaviorsindexdevelopmentandvalidationintwosamplesfromtheunitedkingdom
AT breakwellglynism covid19preventivebehaviorsindexdevelopmentandvalidationintwosamplesfromtheunitedkingdom
AT finoemanuele covid19preventivebehaviorsindexdevelopmentandvalidationintwosamplesfromtheunitedkingdom
AT jaspalrusi covid19preventivebehaviorsindexdevelopmentandvalidationintwosamplesfromtheunitedkingdom